Arrowhead Pharmaceuticals, Inc. financial data

Symbol
ARWR on Nasdaq
Industry
Pharmaceutical Preparations
Location
177 E Colorado Blvd, Suite 700, Pasadena, California
State of incorporation
Delaware
Fiscal year end
September 30
Former names
ARROWHEAD RESEARCH CORP (to 4/6/2016), INTERACTIVE GROUP INC (to 1/9/2004), INTERACTIVE INC (to 2/13/2002)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 497 % +2.68%
Return On Equity -166 % -282%
Return On Assets -66.7 % -201%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +16%
Common Stock, Shares, Outstanding 124M shares +16%
Entity Public Float 2.3B USD -43.9%
Common Stock, Value, Issued 217K USD +9.05%
Weighted Average Number of Shares Outstanding, Basic 124M shares +16.1%
Weighted Average Number of Shares Outstanding, Diluted 124M shares +16.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 19.6M USD -92.3%
General and Administrative Expense 97M USD -3.05%
Operating Income (Loss) -547M USD -203%
Nonoperating Income (Expense) -1.45M USD -271%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -549M USD -205%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -539M USD -197%
Earnings Per Share, Basic -4.67 USD/shares -175%
Earnings Per Share, Diluted -4.66 USD/shares -174%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.4M USD -34.1%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 4.18M USD -41.6%
Assets, Current 450M USD -4.28%
Property, Plant and Equipment, Net 376M USD +62.5%
Operating Lease, Right-of-Use Asset 44.3M USD +9.03%
Other Assets, Noncurrent 4.46M USD +2024%
Assets 884M USD +11%
Accounts Payable, Current 26.6M USD +237%
Employee-related Liabilities, Current 15.8M USD +256%
Accrued Liabilities, Current 47.9M USD +25.4%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 96.7M USD +37.7%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 112M USD +40.2%
Other Liabilities, Noncurrent 669K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -987K USD -140%
Retained Earnings (Accumulated Deficit) -1.45B USD -58.8%
Stockholders' Equity Attributable to Parent 331M USD -9.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 339M USD -11.3%
Liabilities and Equity 884M USD +11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -118M USD -56%
Net Cash Provided by (Used in) Financing Activities 267K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 64.8M USD
Common Stock, Shares Authorized 290M shares 0%
Common Stock, Shares, Issued 124M shares +16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 94.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 69.4M USD -34.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 285M USD +17.4%
Deferred Tax Assets, Gross 304M USD +15.8%
Operating Lease, Liability 118M USD +42.7%
Payments to Acquire Property, Plant, and Equipment 68.7M USD +76.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -154M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid 192M USD +30%
Property, Plant and Equipment, Gross 430M USD +59%
Operating Lease, Liability, Current 6.05M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.7M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.4M USD +89.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 73.5M USD +13.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.9M USD +22.4%
Deferred Tax Assets, Operating Loss Carryforwards 60.5M USD -64.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 14.5M USD +318%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.5M USD +19.4%
Operating Lease, Payments 8.22M USD +70%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD 0%
Depreciation, Depletion and Amortization 15.6M USD +62.5%
Share-based Payment Arrangement, Expense 14.7M USD -26.3%
Interest Expense 23M USD +43.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%